Published in J Gene Med on October 01, 2011
Progress in gene therapy of dystrophic heart disease. Gene Ther (2012) 0.96
Long-term robust myocardial transduction of the dog heart from a peripheral vein by adeno-associated virus serotype-8. Hum Gene Ther (2013) 0.93
Gene therapy for cardiovascular disease: advances in vector development, targeting, and delivery for clinical translation. Cardiovasc Res (2015) 0.89
Gene delivery technologies for cardiac applications. Gene Ther (2012) 0.87
Opsin spectral sensitivity determines the effectiveness of optogenetic termination of ventricular fibrillation in the human heart: a simulation study. J Physiol (2016) 0.87
AAV-8 is more efficient than AAV-9 in transducing neonatal dog heart. Hum Gene Ther Methods (2015) 0.81
Efficacy and safety of myocardial gene transfer of adenovirus, adeno-associated virus and lentivirus vectors in the mouse heart. Gene Ther (2015) 0.80
Minimally invasive closed-chest ultrasound-guided substance delivery into the pericardial space in mice. Naunyn Schmiedebergs Arch Pharmacol (2012) 0.79
X-linked inhibitor of apoptosis protein-mediated attenuation of apoptosis, using a novel cardiac-enhanced adeno-associated viral vector. Hum Gene Ther (2012) 0.79
Myocardial gene transfer: routes and devices for regulation of transgene expression by modulation of cellular permeability. Hum Gene Ther (2013) 0.78
Gene therapy for the prevention of vein graft disease. Transl Res (2012) 0.78
Cardiac gene therapy: are we there yet? Gene Ther (2016) 0.77
Gene therapy for heart failure: where do we stand? Curr Cardiol Rep (2013) 0.76
Prospect of gene therapy for cardiomyopathy in hereditary muscular dystrophy. Expert Opin Orphan Drugs (2015) 0.75
The Use of Gene Therapy for Ablation of Atrial Fibrillation. Arrhythm Electrophysiol Rev (2014) 0.75
Live cell imaging of primary rat neonatal cardiomyocytes following adenoviral and lentiviral transduction using confocal spinning disk microscopy. J Vis Exp (2014) 0.75
In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector. Science (1996) 28.95
Lipofection: a highly efficient, lipid-mediated DNA-transfection procedure. Proc Natl Acad Sci U S A (1987) 18.91
ADENOVIRUS-ASSOCIATED DEFECTIVE VIRUS PARTICLES. Science (1965) 9.77
Site-specific integration by adeno-associated virus. Proc Natl Acad Sci U S A (1990) 7.06
Adenovirus-mediated transfer of a recombinant alpha 1-antitrypsin gene to the lung epithelium in vivo. Science (1991) 6.28
In vivo transfer of the human cystic fibrosis transmembrane conductance regulator gene to the airway epithelium. Cell (1992) 5.85
Analysis of AAV serotypes 1-9 mediated gene expression and tropism in mice after systemic injection. Mol Ther (2008) 5.83
Systemic delivery of genes to striated muscles using adeno-associated viral vectors. Nat Med (2004) 5.59
Adeno-associated virus serotype 8 efficiently delivers genes to muscle and heart. Nat Biotechnol (2005) 5.27
Robust systemic transduction with AAV9 vectors in mice: efficient global cardiac gene transfer superior to that of AAV8. Mol Ther (2006) 4.64
Widespread long-term gene transfer to mouse skeletal muscles and heart. J Clin Invest (1992) 4.43
Circular intermediates of recombinant adeno-associated virus have defined structural characteristics responsible for long-term episomal persistence in muscle tissue. J Virol (1998) 4.17
Viral vectors for gene therapy: the art of turning infectious agents into vehicles of therapeutics. Nat Med (2001) 4.02
New recombinant serotypes of AAV vectors. Curr Gene Ther (2005) 3.87
Systemic delivery of morpholino oligonucleotide restores dystrophin expression bodywide and improves dystrophic pathology. Nat Med (2006) 3.74
Recombinant adeno-associated virus serotype 9 leads to preferential cardiac transduction in vivo. Circ Res (2006) 3.63
Gene therapy for myocardial angiogenesis: initial clinical results with direct myocardial injection of phVEGF165 as sole therapy for myocardial ischemia. Circulation (1999) 2.92
Calcium upregulation by percutaneous administration of gene therapy in cardiac disease (CUPID Trial), a first-in-human phase 1/2 clinical trial. J Card Fail (2009) 2.89
Chronic suppression of heart-failure progression by a pseudophosphorylated mutant of phospholamban via in vivo cardiac rAAV gene delivery. Nat Med (2002) 2.37
Adeno-associated virus (AAV) serotype 9 provides global cardiac gene transfer superior to AAV1, AAV6, AAV7, and AAV8 in the mouse and rat. Hum Gene Ther (2008) 2.27
Microdystrophin gene therapy of cardiomyopathy restores dystrophin-glycoprotein complex and improves sarcolemma integrity in the mdx mouse heart. Circulation (2003) 2.22
A single intravenous injection of adeno-associated virus serotype-9 leads to whole body skeletal muscle transduction in dogs. Mol Ther (2008) 2.22
Modulation of ventricular function through gene transfer in vivo. Proc Natl Acad Sci U S A (1998) 2.19
Design of a phase 1/2 trial of intracoronary administration of AAV1/SERCA2a in patients with heart failure. J Card Fail (2008) 2.09
Effective rescue of dystrophin improves cardiac function in dystrophin-deficient mice by a modified morpholino oligomer. Proc Natl Acad Sci U S A (2008) 2.06
Systemic AAV-9 transduction in mice is influenced by animal age but not by the route of administration. Gene Ther (2007) 2.01
Engineering liver-detargeted AAV9 vectors for cardiac and musculoskeletal gene transfer. Mol Ther (2011) 1.86
A myocardium tropic adeno-associated virus (AAV) evolved by DNA shuffling and in vivo selection. Proc Natl Acad Sci U S A (2009) 1.85
Angiogenesis gene therapy: phase I assessment of direct intramyocardial administration of an adenovirus vector expressing VEGF121 cDNA to individuals with clinically significant severe coronary artery disease. Circulation (1999) 1.82
Quantitative determination of adenovirus-mediated gene delivery to rat cardiac myocytes in vitro and in vivo. Proc Natl Acad Sci U S A (1993) 1.72
Expression of recombinant genes in myocardium in vivo after direct injection of DNA. Circulation (1990) 1.72
Evidence for the failure of adeno-associated virus serotype 5 to package a viral genome > or = 8.2 kb. Mol Ther (2009) 1.64
Phase 1/2 placebo-controlled, double-blind, dose-escalating trial of myocardial vascular endothelial growth factor 2 gene transfer by catheter delivery in patients with chronic myocardial ischemia. Circulation (2002) 1.61
Efficient gene transfer into myocardium by direct injection of adenovirus vectors. Circ Res (1993) 1.51
Efficient whole-body transduction with trans-splicing adeno-associated viral vectors. Mol Ther (2007) 1.48
Tetracycline-regulated cardiac gene expression in vivo. J Clin Invest (1994) 1.46
Direct in vivo gene transfer into porcine myocardium using replication-deficient adenoviral vectors. Circulation (1994) 1.45
VEGF gene therapy fails to improve perfusion of ischemic myocardium in patients with advanced coronary disease: results of the NORTHERN trial. Mol Ther (2009) 1.37
Gene transfer in vivo with DNA-liposome complexes: safety and acute toxicity in mice. Hum Gene Ther (1992) 1.28
Efficient and stable transduction of cardiomyocytes after intramyocardial injection or intracoronary perfusion with recombinant adeno-associated virus vectors. Circulation (1999) 1.28
Cardio-specific long-term gene expression in a porcine model after selective pressure-regulated retroinfusion of adeno-associated viral (AAV) vectors. Gene Ther (2007) 1.23
Gene therapy of mdx mice with large truncated dystrophins generated by recombination using rAAV6. Mol Ther (2010) 1.21
Angiogenic gene therapy in patients with nonrevascularizable ischemic heart disease: a phase 2 randomized, controlled trial of AdVEGF(121) (AdVEGF121) versus maximum medical treatment. Gene Ther (2006) 1.18
SERCA2a gene transfer enhances eNOS expression and activity in endothelial cells. Mol Ther (2010) 1.18
Percutaneous transendocardial delivery of self-complementary adeno-associated virus 6 achieves global cardiac gene transfer in canines. Mol Ther (2008) 1.18
Restoration of deficient membrane proteins in the cardiomyopathic hamster by in vivo cardiac gene transfer. Circulation (2002) 1.14
Evaluation of vascular delivery methodologies to enhance rAAV6-mediated gene transfer to canine striated musculature. Mol Ther (2009) 1.13
Enhancement of cardiac function after adenoviral-mediated in vivo intracoronary beta2-adrenergic receptor gene delivery. J Clin Invest (1999) 1.12
Myocardial gene transfer and long-term expression following intracoronary delivery of adeno-associated virus. J Gene Med (2005) 1.12
Infectious molecular clones of adeno-associated virus isolated directly from human tissues. J Virol (2008) 1.11
Efficient and long-term intracardiac gene transfer in delta-sarcoglycan-deficiency hamster by adeno-associated virus-2 vectors. Gene Ther (2003) 1.11
Multiply attenuated, self-inactivating lentiviral vectors efficiently deliver and express genes for extended periods of time in adult rat cardiomyocytes in vivo. Circulation (2003) 1.09
Plasmid-based transient human stromal cell-derived factor-1 gene transfer improves cardiac function in chronic heart failure. Gene Ther (2011) 1.08
Behavior of genes directly injected into the rat heart in vivo. Circ Res (1992) 1.08
Expanding adeno-associated viral vector capacity: a tale of two vectors. Biotechnol Genet Eng Rev (2007) 1.06
High-efficiency, long-term cardiac expression of foreign genes in living mouse embryos and neonates. Circulation (2000) 1.06
Lentiviral vector-mediated SERCA2 gene transfer protects against heart failure and left ventricular remodeling after myocardial infarction in rats. Mol Ther (2008) 1.05
Cardiac gene therapy with SERCA2a: from bench to bedside. J Mol Cell Cardiol (2010) 1.05
Distinct behavior of cardiac myosin heavy chain gene constructs in vivo. Discordance with in vitro results. Circ Res (1993) 1.04
Gene therapy with vascular endothelial growth factor for inoperable coronary artery disease. Ann Thorac Surg (1999) 1.02
Gene delivery to the myocardium by intrapericardial injection. Gene Ther (1999) 1.02
Lentiviral vectors for delivery of genes into neonatal and adult ventricular cardiac myocytes in vitro and in vivo. Basic Res Cardiol (2002) 1.00
Novel polymer carriers and gene constructs for treatment of myocardial ischemia and infarction. J Control Release (2008) 0.96
One-year follow-up of direct myocardial gene transfer of vascular endothelial growth factor-2 using naked plasmid deoxyribonucleic acid by way of thoracotomy in no-option patients. Am J Cardiol (2003) 0.93
Highly efficient DNA delivery mediated by pH-sensitive immunoliposomes. Biochemistry (1989) 0.92
In vivo gene transfer by intravenous administration of stable cationic lipid/DNA complex. Pharm Res (1997) 0.91
AAV serotype 1 mediates more efficient gene transfer to pig myocardium than AAV serotype 2 and plasmid. J Gene Med (2008) 0.90
A randomised, double-blind, placebo-controlled, multicentre study of the safety and efficacy of BIOBYPASS (AdGVVEGF121.10NH) gene therapy in patients with refractory advanced coronary artery disease: the NOVA trial. EuroIntervention (2011) 0.84
A randomized, double-blind, placebo-controlled, multicenter, pilot study of the safety and feasibility of catheter-based intramyocardial injection of AdVEGF121 in patients with refractory advanced coronary artery disease. Catheter Cardiovasc Interv (2006) 0.84
Gene transfer into the donor heart during cold preservation for heart transplantation. Ann Thorac Surg (1998) 0.76
Characterization of promoter elements of the rabbit cardiac sarcoplasmic reticulum Ca(2+)-ATPase gene required for expression in cardiac muscle cells. Circ Res (1993) 0.76
Modular flexibility of dystrophin: implications for gene therapy of Duchenne muscular dystrophy. Nat Med (2002) 5.07
Dystrophins carrying spectrin-like repeats 16 and 17 anchor nNOS to the sarcolemma and enhance exercise performance in a mouse model of muscular dystrophy. J Clin Invest (2009) 2.89
Microdystrophin gene therapy of cardiomyopathy restores dystrophin-glycoprotein complex and improves sarcolemma integrity in the mdx mouse heart. Circulation (2003) 2.22
A single intravenous injection of adeno-associated virus serotype-9 leads to whole body skeletal muscle transduction in dogs. Mol Ther (2008) 2.22
Efficient in vivo gene expression by trans-splicing adeno-associated viral vectors. Nat Biotechnol (2005) 2.16
Adeno-associated virus-mediated microdystrophin expression protects young mdx muscle from contraction-induced injury. Mol Ther (2005) 2.08
The passive mechanical properties of the extensor digitorum longus muscle are compromised in 2- to 20-mo-old mdx mice. J Appl Physiol (1985) (2011) 1.75
Prevention of dystrophin-deficient cardiomyopathy in twenty-one-month-old carrier mice by mosaic dystrophin expression or complementary dystrophin/utrophin expression. Circ Res (2007) 1.65
Evidence for impaired neurovascular transmission in a murine model of Duchenne muscular dystrophy. J Appl Physiol (1985) (2010) 1.64
Evidence for the failure of adeno-associated virus serotype 5 to package a viral genome > or = 8.2 kb. Mol Ther (2009) 1.64
Systemic Trans-splicing adeno-associated viral delivery efficiently transduces the heart of adult mdx mouse, a model for duchenne muscular dystrophy. Hum Gene Ther (2009) 1.53
Efficient whole-body transduction with trans-splicing adeno-associated viral vectors. Mol Ther (2007) 1.48
Cardiac expression of a mini-dystrophin that normalizes skeletal muscle force only partially restores heart function in aged Mdx mice. Mol Ther (2008) 1.36
Viral serotype and the transgene sequence influence overlapping adeno-associated viral (AAV) vector-mediated gene transfer in skeletal muscle. J Gene Med (2006) 1.36
Adeno-associated virus serotype-9 microdystrophin gene therapy ameliorates electrocardiographic abnormalities in mdx mice. Hum Gene Ther (2008) 1.36
Preservation of muscle force in Mdx3cv mice correlates with low-level expression of a near full-length dystrophin protein. Am J Pathol (2008) 1.33
A hybrid vector system expands adeno-associated viral vector packaging capacity in a transgene-independent manner. Mol Ther (2007) 1.31
Adeno-associated virus serotype 6 capsid tyrosine-to-phenylalanine mutations improve gene transfer to skeletal muscle. Hum Gene Ther (2010) 1.26
Full-length dystrophin expression in half of the heart cells ameliorates beta-isoproterenol-induced cardiomyopathy in mdx mice. Hum Mol Genet (2004) 1.25
Monitoring murine skeletal muscle function for muscle gene therapy. Methods Mol Biol (2011) 1.22
Transduction efficiency and immune response associated with the administration of AAV8 vector into dog skeletal muscle. Mol Ther (2008) 1.21
Nitrosative stress elicited by nNOSµ delocalization inhibits muscle force in dystrophin-null mice. J Pathol (2010) 1.20
An intronic LINE-1 element insertion in the dystrophin gene aborts dystrophin expression and results in Duchenne-like muscular dystrophy in the corgi breed. Lab Invest (2010) 1.20
Trans-splicing adeno-associated viral vector-mediated gene therapy is limited by the accumulation of spliced mRNA but not by dual vector coinfection efficiency. Hum Gene Ther (2004) 1.16
Sarcolemmal nNOS anchoring reveals a qualitative difference between dystrophin and utrophin. J Cell Sci (2010) 1.14
Marginal level dystrophin expression improves clinical outcome in a strain of dystrophin/utrophin double knockout mice. PLoS One (2010) 1.14
Efficient transgene reconstitution with hybrid dual AAV vectors carrying the minimized bridging sequences. Hum Gene Ther (2010) 1.14
Microdystrophin ameliorates muscular dystrophy in the canine model of duchenne muscular dystrophy. Mol Ther (2013) 1.13
Novel mini-dystrophin gene dual adeno-associated virus vectors restore neuronal nitric oxide synthase expression at the sarcolemma. Hum Gene Ther (2011) 1.13
Sub-physiological sarcoglycan expression contributes to compensatory muscle protection in mdx mice. Hum Mol Genet (2009) 1.12
α2 and α3 helices of dystrophin R16 and R17 frame a microdomain in the α1 helix of dystrophin R17 for neuronal NOS binding. Proc Natl Acad Sci U S A (2012) 1.11
AAV-microdystrophin therapy improves cardiac performance in aged female mdx mice. Mol Ther (2011) 1.08
Expanding adeno-associated viral vector capacity: a tale of two vectors. Biotechnol Genet Eng Rev (2007) 1.06
Age-matched comparison reveals early electrocardiography and echocardiography changes in dystrophin-deficient dogs. Neuromuscul Disord (2011) 1.04
Whole body skeletal muscle transduction in neonatal dogs with AAV-9. Methods Mol Biol (2011) 1.03
Genotyping mdx, mdx3cv, and mdx4cv mice by primer competition polymerase chain reaction. Muscle Nerve (2010) 1.03
AAV micro-dystrophin gene therapy alleviates stress-induced cardiac death but not myocardial fibrosis in >21-m-old mdx mice, an end-stage model of Duchenne muscular dystrophy cardiomyopathy. J Mol Cell Cardiol (2012) 1.00
A simplified immune suppression scheme leads to persistent micro-dystrophin expression in Duchenne muscular dystrophy dogs. Hum Gene Ther (2011) 1.00
Dual AAV therapy ameliorates exercise-induced muscle injury and functional ischemia in murine models of Duchenne muscular dystrophy. Hum Mol Genet (2013) 0.99
Gender influences cardiac function in the mdx model of Duchenne cardiomyopathy. Muscle Nerve (2010) 0.99
Double strand interaction is the predominant pathway for intermolecular recombination of adeno-associated viral genomes. Virology (2003) 0.99
Gender differences in contractile and passive properties of mdx extensor digitorum longus muscle. Muscle Nerve (2012) 0.98
Adeno-associated virus serotype-9 efficiently transduces the retinal outer plexiform layer. Mol Vis (2009) 0.97
Ectopic catalase expression in mitochondria by adeno-associated virus enhances exercise performance in mice. PLoS One (2009) 0.95
Recombinant AAV-mediated gene delivery using dual vector heterodimerization. Methods Enzymol (2002) 0.95
Synthetic intron improves transduction efficiency of trans-splicing adeno-associated viral vectors. Hum Gene Ther (2006) 0.95
Exclusive skeletal muscle correction does not modulate dystrophic heart disease in the aged mdx model of Duchenne cardiomyopathy. Hum Mol Genet (2013) 0.94
Phenotyping cardiac gene therapy in mice. Methods Mol Biol (2011) 0.94
Long-term robust myocardial transduction of the dog heart from a peripheral vein by adeno-associated virus serotype-8. Hum Gene Ther (2013) 0.93
Evaluation of muscle function of the extensor digitorum longus muscle ex vivo and tibialis anterior muscle in situ in mice. J Vis Exp (2013) 0.93
Novel CLCN1 mutations and clinical features of Korean patients with myotonia congenita. J Korean Med Sci (2009) 0.93
SERCA2a gene transfer improves electrocardiographic performance in aged mdx mice. J Transl Med (2011) 0.92
Recombinant adeno-associated viral vector production and purification. Methods Mol Biol (2012) 0.92
Phenotypic variability in Kennedy's disease: implication of the early diagnostic features. Acta Neurol Scand (2005) 0.92
Dystrophin deficiency compromises force production of the extensor carpi ulnaris muscle in the canine model of Duchenne muscular dystrophy. PLoS One (2012) 0.90
Humoral immunity to AAV-6, 8, and 9 in normal and dystrophic dogs. Hum Gene Ther (2012) 0.89
Quantitative phenotyping of Duchenne muscular dystrophy dogs by comprehensive gait analysis and overnight activity monitoring. PLoS One (2013) 0.89
Full-length dystrophin reconstitution with adeno-associated viral vectors. Hum Gene Ther (2014) 0.89
Limb-girdle phenotype is frequent in patients with myopathy associated with GNE mutations. J Neurol Sci (2012) 0.86
A case of Lambert-Eaton myasthenic syndrome associated with atypical bronchopulmonary carcinoid tumor. J Korean Med Sci (2004) 0.84
iNOS ablation does not improve specific force of the extensor digitorum longus muscle in dystrophin-deficient mdx4cv mice. PLoS One (2011) 0.83
Design of trans-splicing adeno-associated viral vectors for Duchenne muscular dystrophy gene therapy. Methods Mol Biol (2008) 0.82
Adenovirus-mediated gene transfer to adult mouse cardiomyocytes is selectively influenced by culture medium. J Gene Med (2003) 0.81
NUDT15 variant is the most common variant associated with thiopurine-induced early leukopenia and alopecia in Korean pediatric patients with Crohn's disease. Eur J Gastroenterol Hepatol (2016) 0.81
AAV-8 is more efficient than AAV-9 in transducing neonatal dog heart. Hum Gene Ther Methods (2015) 0.81
Adeno-associated virus serotype-9 mediated retinal outer plexiform layer transduction is mainly through the photoreceptors. Adv Exp Med Biol (2010) 0.81
Possible anticipation associated with a novel splice site mutation in episodic ataxia type 2. Neurol Sci (2013) 0.80
Truncated dystrophins reduce muscle stiffness in the extensor digitorum longus muscle of mdx mice. J Appl Physiol (1985) (2012) 0.80
A marginal level of dystrophin partially ameliorates hindlimb muscle passive mechanical properties in dystrophin-null mice. Muscle Nerve (2012) 0.79
Catalase overexpression does not impair extensor digitorum longus muscle function in normal mice. Muscle Nerve (2007) 0.79
Effect of enzyme replacement therapy in late onset Pompe disease: open pilot study of 48 weeks follow-up. Neurol Sci (2014) 0.79
Recombinant adeno-associated virus type 8-mediated extensive therapeutic gene delivery into skeletal muscle of alpha-sarcoglycan-deficient mice. Hum Gene Ther (2008) 0.78
Electrophysiological characteristics of six mutations in hClC-1 of Korean patients with myotonia congenita. Mol Cells (2014) 0.78
Gene delivery to the heart: an updated review on vectors and methods. J Gene Med (2011) 0.78
Exercise-induced downbeat nystagmus in a Korean family with a nonsense mutation in CACNA1A. Neurol Sci (2015) 0.77
Alpha 7 integrin preserves the function of the extensor digitorum longus muscle in dystrophin-null mice. J Appl Physiol (1985) (2013) 0.77
Rebound upbeat nystagmus after lateral gaze in episodic ataxia type 2. Cerebellum (2014) 0.77
Perspectives on best practices for gene therapy programs. Hum Gene Ther (2015) 0.76
A recurrent longitudinally extensive transverse myelitis with Aquaporin-4(AQP4) antibody after herpes zoster. J Neurol Sci (2013) 0.75
Mitochondria-targeted antiaging gene therapy with adeno-associated viral vectors. Methods Mol Biol (2013) 0.75
Isolated unilateral leg weakness as the presenting symptom of primary aldosteronism: a case report. Acta Neurol Belg (2014) 0.75
Efficient Whole-body Transduction with Trans-splicing Adeno-associated Viral Vectors. Mol Ther (2016) 0.75